Impact of humoral immune response against p53 on clinical outcome of High-Grade Serous Ovarian Cancer (HGSOC) patients

被引：0
|
作者：
Garziera, M. [1 ]
Cecchin, E. [1 ]
Montico, M. [1 ]
Roncato, R. [1 ]
Gagno, S. [1 ]
De Mattia, E. [1 ]
Sorio, R. [2 ]
Scalone, S. [2 ]
Poletto, E. [3 ]
Toffoli, G. [1 ]
机构：
[1] Natl Canc Inst, CRO, Expt & Clin Pharmacol Unit, Aviano, Italy
[2] Natl Canc Inst, CRO, Oncol Unit C, Aviano, Italy
[3] Univ Udine, Dept Oncol, Udine, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
24P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gene set enrichment clustering and the tumor microenvironment in primary high-grade serous ovarian cancer (HGSOC)
    Cybulska, P.
    Jimenez-Sanchez, A.
    LaVigne, K.
    Walther, T.
    Vargas, H. A.
    Zivanovic, O.
    Weigelt, B.
    Sala, E.
    Miller, M.
    Snyder, A.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 25 - 25
  • [42] MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
    Baath, Maria
    Jonsson, Jenny-Maria
    Fremer, Sofia Westbom
    de la Fuente, Laura Martin
    Tran, Lena
    Malander, Susanne
    Kannisto, Paivi
    Masback, Anna
    Honeth, Gabriella
    Hedenfalk, Ingrid
    GENES, 2021, 12 (05)
  • [43] Determinants of clinical outcome in high grade serous ovarian cancer
    Bowtell, David D. L.
    Cown, Prue
    Etemadmoghadam, Dariush
    Alsop, Kathryn
    George, Joshy
    de Fazaio, Anna
    Mitchell, Gillian
    CANCER RESEARCH, 2012, 72
  • [44] The tumor immune microenvironment modulates response to chemotherapy in high-grade serous epithelial ovarian cancer
    Koti, Madhuri
    Edwards, Andrew
    Squire, Jeremy A.
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Peritoneal tumor spread in high-grade serous ovarian cancer: Differences in the immune response.
    Auer, Katharina
    Bachmayr-Heyda, Anna
    Sukhbaatar, Nyamdelger
    Aust, Stefanie
    Grimm, Christoph
    Horvat, Reinhard
    Pils, Dietmar
    CLINICAL CANCER RESEARCH, 2016, 22
  • [46] A 2-Protein Signature Predicting Clinical Outcome in High-Grade Serous Ovarian Cancer
    Jin, Chengjuan
    Xue, Yingfeng
    Li, Yingwei
    Bu, Hualei
    Yu, Hongfeng
    Zhang, Tao
    Zhang, Zhiwei
    Yan, Shi
    Lu, Nan
    Kong, Beihua
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (01) : 51 - 58
  • [47] High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
    Hatano, Yuichiro
    Fukuda, Shinya
    Makino, Hiroshi
    Tomita, Hiroyuki
    Morishige, Ken-ichirou
    Hara, Akira
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [48] High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
    Yuichiro Hatano
    Shinya Fukuda
    Hiroshi Makino
    Hiroyuki Tomita
    Ken-ichirou Morishige
    Akira Hara
    Diagnostic Pathology, 13
  • [49] Transcriptomic profiles of response to neoadjuvant chemotherapy in patients with high-grade serous ovarian cancer
    Lee, Sanghoon
    Zhao, Li
    Fleming, Nicole D.
    Celestino, Joseph
    Hajek, Richard A.
    Morgan, Margaret B.
    Liu, Yan
    Westin, Shannon N.
    Jazaeri, Amir A.
    Liu, Jinsong
    Zhang, Jianhua
    Futreal, P. Andrew
    Sood, Anil K.
    CANCER RESEARCH, 2022, 82 (12)
  • [50] Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)
    Garziera, Marica
    Cecchin, Erika
    Canzonieri, Vincenzo
    Sorio, Roberto
    Giorda, Giorgio
    Scalone, Simona
    De Mattia, Elena
    Roncato, Rossana
    Gagno, Sara
    Poletto, Elena
    Romanato, Loredana
    Sartor, Franca
    Polesel, Jerry
    Toffoli, Giuseppe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
12345